Loading…
Comment on: “Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing”
In our study, which was published in a Science Citation Index-Expanded (SCI-E) journal and can also be accessed in Pubmed, we investigated the effects of cilostazol and aspirin on wound healing in DFU patients with peripheral arterial disease (PAD) [2]. The mean duration of treatment was 1.31 months...
Saved in:
Published in: | Drugs (New York, N.Y.) N.Y.), 2022-03, Vol.82 (4), p.485-486 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In our study, which was published in a Science Citation Index-Expanded (SCI-E) journal and can also be accessed in Pubmed, we investigated the effects of cilostazol and aspirin on wound healing in DFU patients with peripheral arterial disease (PAD) [2]. The mean duration of treatment was 1.31 months (1-2 months) in the cilostazol group and 1.82 months (1-2.5 months) in the aspirin group (p < 0,05) [2]. Because of the risk of pulmonary arterial hypertension (PAH) in patients with DFUs, an antiaggregant therapy such as aspirin or cilostazol should be initiated. [...]of our study, it can be said that cilostazol is more effective than aspirin in the recovery of symptoms of PAD and effective treatment of DFUs. |
---|---|
ISSN: | 0012-6667 1179-1950 |
DOI: | 10.1007/s40265-022-01673-8 |